rs2834171
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000628.5(IL10RB):c.498+698G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.48 in 151,924 control chromosomes in the GnomAD database, including 18,198 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.48 ( 18198 hom., cov: 32)
Consequence
IL10RB
NM_000628.5 intron
NM_000628.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.24
Publications
2 publications found
Genes affected
IL10RB (HGNC:5965): (interleukin 10 receptor subunit beta) The protein encoded by this gene belongs to the cytokine receptor family. It is an accessory chain essential for the active interleukin 10 receptor complex. Coexpression of this and IL10RA proteins has been shown to be required for IL10-induced signal transduction. This gene and three other interferon receptor genes, IFAR2, IFNAR1, and IFNGR2, form a class II cytokine receptor gene cluster located in a small region on chromosome 21. [provided by RefSeq, Jul 2008]
IL10RB Gene-Disease associations (from GenCC):
- inflammatory bowel disease 25Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- IL10-related early-onset inflammatory bowel diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.611 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| IL10RB | NM_000628.5 | c.498+698G>T | intron_variant | Intron 4 of 6 | ENST00000290200.7 | NP_000619.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.480 AC: 72846AN: 151806Hom.: 18174 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
72846
AN:
151806
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.480 AC: 72906AN: 151924Hom.: 18198 Cov.: 32 AF XY: 0.476 AC XY: 35330AN XY: 74248 show subpopulations
GnomAD4 genome
AF:
AC:
72906
AN:
151924
Hom.:
Cov.:
32
AF XY:
AC XY:
35330
AN XY:
74248
show subpopulations
African (AFR)
AF:
AC:
25557
AN:
41416
American (AMR)
AF:
AC:
5980
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
AC:
1827
AN:
3464
East Asian (EAS)
AF:
AC:
1052
AN:
5168
South Asian (SAS)
AF:
AC:
1757
AN:
4810
European-Finnish (FIN)
AF:
AC:
5048
AN:
10546
Middle Eastern (MID)
AF:
AC:
128
AN:
294
European-Non Finnish (NFE)
AF:
AC:
30325
AN:
67940
Other (OTH)
AF:
AC:
947
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1909
3817
5726
7634
9543
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
640
1280
1920
2560
3200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
906
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.